[凝血功能的测试:原理和临床应用]
1Department of Transfusion Medicine, Nagoya University Hospital.
[Rinsho ketsueki] The Japanese journal of clinical hematology
|October 1, 2025
概括
凝血波形分析 (CWA) 提供了一种标准化方法来评估血液凝固,超越了像旋转血栓等传统测试 (ROTEM). 我们的研究开发了一种基于CWA的诊断工具,用于治疗纤维蛋白发育不良,从而提高了临床诊断.
科学领域:
- 生物化学 生化学
- 血液学 血液学 血液学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 标准化全面的血液凝固功能测试仍然具有挑战性,限制了它们的研究应用.
- 旋转血小板测量 (ROTEM) 是一种常见的临床治疗点测试,但与其他方法相比,它提供了不那么有用的数据.
- 现有的凝血试验往往缺乏标准化和全面的数据分析能力.
研究的目的:
- 开发一种新的诊断工具,用于使用凝血波形分析 (CWA) 治疗纤维蛋白缺血症.
- 实施CWA以加强血液凝固反应的分析.
- 提高血液凝固测试的标准化和数据产量.
主要方法:
- 凝血波形分析 (CWA) 用于分析纤维原-纤维素转换过程中随时间变化的度.
- 使用CWA原则开发了一个诊断工具.
- 开发的CWA工具作为Sysmex自动化血液凝固分析仪上的应用程序.
主要成果:
- 与ROTEM等传统方法相比,CWA提供了更可用的数据.
- 开发的基于CWA的诊断工具有效地分析了凝血反应.
- 在自动化分析器上实现的实现有助于大规模的数据收集和分析.
结论:
- CWA提供了一种标准化,数据丰富的血液凝固分析方法.
- 开发的诊断工具对识别纤维蛋白发育不良症有希望.
- 与CWA集成的自动分析仪可以显著提升凝血诊断.
更多相关视频
相关概念视频
Coagulation
9.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.7K
Coagulation
1.2K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Extrinsic and Intrinsic Pathways of Hemostasis
12.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.1K
Introduction to Hemostasis
13.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.4K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K


